Pancreaticobiliary Symposium 2014

Sunday, November 2, 2014
7:30 a.m.-2:30 p.m.
John Theuer Cancer Center
This program is designed to provide physicians, nurses and other healthcare providers with a review of the state-of-the-art diagnostic, medical and surgical management of pancreas cancer.
Experts in the field will present on:
  • Screening for Pancreas Cancer
  • Medical Management of Pancreas Cancer
  • The Future of Pancreas Cancer Treatment
  • Unique Surgical Challenges in Pediatric
  • Pacreaticobiliary Disease
  • Surgery for Unresectable Pancreas Cancer
  • Advanced Endoscopic Treatment for Benign Pancreas Disease
  • Under The Microscope: Pancreaticobiliary Cytology
  • From the Lab to the Bedside: Pancreaticobiliary Molecular Diagnosis
Symposium Objectives:
  • Explain novel strategies for screening and prevention of pancreas cancer
  • Describe state-of-the-art oncologic strategies for treating inoperable pancreas cancer
  • Explain how to potentially downstage pancreas cancer pre-operatively with chemotherapy
  • Analyze future trends in pancreatic cancer including chemotherapy and molecular methods for diagnosis and treatment
  • Distinguish the unique issues involved in operating on and caring for pediatric patients with hepatobiliary and pancreas tumors
  • Describe the future of pediatric hepatobiliary and pancreas surgery
  • Describe the role of surgery in inoperable & locally advanced pancreas cancer
  • Describe advanced endoscopic techniques to manage bile duct stricture and cystic fluid collection in the pancreas
  • Review the unique role of cytology in pancreaticobiliary disease
  • Describe how pancreas cyst mutational profiles help physicians resolve complex diagnostic dilemmas in patients who are at risk of pancreas cancer
  • Explore how data from the National Pancreas Cyst Registry helps risk- stratify patients with pancreas cysts
Credits: Accreditation Statement:
Hackensack University Medical Center is accredited by the Medical Society of
New Jersey to provide continuing medical education
for physicians. AMA Credit Designation Statement: Hackensack University Medical Center designates this live activity for a maximum of 5.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Contact Hours: 5.5.
Hackensack University Medical Center is an approved provider of continuing nursing education by the New Jersey State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission On Accreditation. Provider Number P170-8/12-15. Provider Approval is valid through August 31, 2015.
Registration is required for this complimentary program.
To register or to receive additional information email Evan Epper at

best-hospitals-cardiology    high-performing-indicator-heartfailure    high-performing-indicator-heartbypass     HG_Americas_50_Best_Award_Image_2014      HG_Americas_100_Best_Stroke_Care_Award_Image_2014        HG_Americas_100_Best_Pulmonary_Care_Award_Image_2014     red-bulllgbt      tkc_homepagelogo-2

Translation service provided by Google. Hackensack University Medical Center is not responsible for the accuracy of translation or any other aspect of service provided by the GoogleTranslate tool. Users should not make medical decisions without first consulting with their physician.

Site Map
|Privacy Policy|Media Center

©2017 Hackensack University Medical Center. All rights reserved.
close (X)